Navigation Links
Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference
Date:5/14/2008

SHENZHEN, China, May 14 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that Mr. Minghe Cheng, Mindray's executive vice president of strategic development and Ms. May Li, Mindray's investor relations manager, will present at the Oppenheimer 2nd Annual China Dragon Call Conference to be held at the Oppenheimer & Co. Executive Conference Center in New York City from Tuesday, May 20, 2008 to Thursday, May 22, 2008 and at the 2008 Citi Investment Research Global Healthcare Conference to be held at the Hilton New York Hotel in New York City from Wednesday, May 21, 2008 to Thursday, May 22, 2008.

Presentation Details:

Oppenheimer 2nd Annual Dragon Call Conference

-- Mindray Attendees: Mr. Minghe Cheng, executive vice president of

strategic development, and Ms. May Li, investor relations manager

-- Date: May 20, 2008

-- Time: 8:25-9:05 a.m. (local time)

-- Location: Oppenheimer & Co. Executive Conference Center, New York, NY

-- Webcast:

http://www.veracast.com/webcasts/opco/chinadragon08/02103187.cfm

2008 Citi Investment Research Global Healthcare Conference

-- Mindray Attendees: Mr. Minghe Cheng, executive vice president of

strategic development, and Ms. May Li, investor relations manager

-- Date: May 21, 2008

-- Time: 4:30-4:55 p.m. (local time)

-- Location: The Hilton New York Hotel, New York, NY

Mr. Cheng and Ms. Li will hold one-on-one meetings with investors during th
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Mindray to Report First Quarter 2008 Financial Results on May 7, 2008
2. Mindray to Exhibit at 2008 China International Medical Equipment Fair
3. Mindray to Attend the JPMorgan 4th Annual China Conference
4. Mindrays Laptop-size M5 and BS-200 Receive FDA Clearance
5. Mindray to Attend the 11th Credit Suisse Asian Investment Conference
6. Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results
7. Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5, 2008
8. Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting
9. Mindray to Attend 2008 CLSA Asia Investors Forum
10. Mindray to Attend 2007 RSNA Conference in Chicago
11. Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...RNewswire-USNewswire/ -- SEIU Local 21LA members a... Sodexo will hold a rally Tuesday, Dec. 1, 2009, a...arters, 3800 Desire Parkway, New Orleans, to prote...iplinary policies that target employees who are il...dexo employees who clean schools in the Recovery S...
(Date:11/30/2009)... Harrington Physician Services (HP...ractice physicians Martin Devine, Leah Doret, Eliz...ctice. ,, These four esteemed and popular Cha...nic, will soon join the Harrington family in the n...e building under construction at 10 North Main Str...
(Date:11/30/2009)...tween the registration of a visual stimulus by the... it ― between the time we see an apple and t... behind our eyes, but by how long? And how does th..., Some estimates say the time delay lasts only 1...w study by Tel Aviv University psychologists says ...
(Date:11/30/2009)...h specially designed program, study finds , ...l, intensive early intervention program for toddle... children,s language and social skills, a new stud...ldren are able to learn and make remarkable progre...dy, published online Nov. 30 in Pediatrics , and...
(Date:11/30/2009)...d., Nov. 30 Sunlamps an...ar-round, but the ultraviolet (UV) radiation from ...Logo: http://www.newscom.com/cgi-bin/prnh/2009082...t a tan gives them a ,healthy, glow, any tan is a ..., a Food and Drug Administration (FDA) scientist a...
Breaking Medicine News(10 mins):Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:Now you see it, now you know you see it 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4
...ormal-weight women who carry out lots of vigorous ...lop breast cancer than those who don,t exercise vi...tmenopausal American women, reported in BioMed Cen...re not overweight. , While an Investigator at the...
...oved laboratory efficiencies and standardization t... care, PLEASANTON, Calif., Oct. 30 Roche Mol...ood & Drug Administration (FDA) has approved,the C...he amount of Hepatitis C RNA in a patient,s blood....
...LOUIS, Oct. 30 Schering-Plough,Corporation (NYSE:...the,decision reached by a jury in Missouri related...f certain products sold by Warrick,Pharmaceuticals...ble laws and regulations governing reimbursement r...
...ing Pediatricians Refute MD Who Signed Prop 8 Ball...on Prop 8 campaign,today released a statement sign...ns announcing their joint opposition to Prop 8 and...sue., The pediatrician statement took issue with ...
...OLUMBIA, Mo. Long after a conflict, landmines rem...nd detonate them. According to the United Nations ...ried in 68 countries around the world. The UN est...he accuracy of a landmine radar system while minim...
...TANFORD, Calif. Investigators combing the genome ...le for triggering early-onset diabetes ,may be loo...ord ,University School of Medicine suggests. , Ea...lls in a person,s pancreas. , What triggers that ...
Other Medicine News:Health News:Vigorous activity protects against breast cancer 2Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 2Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 3Health News:Schering-Plough to Appeal Jury Decision in Missouri Reimbursement Case 2Health News:NO on Prop 8 Campaign Releases Statement by 300 California Pediatricians 2Health News:Engineer creating more sensitive, safer landmine detectors 2Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 2Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 3Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 4
(Date:11/30/2009)...v. 30 The U.S. Food and ...74; (duloxetine HCl) for the maintenance treatment...Eli Lilly and Company (NYSE: LLY ) announced tod...be a chronic illness, it is important that doctors...s effective in both the acute and maintenance phas...
(Date:11/30/2009)...ewswire/ -- Stemline Therapeutics, Inc., a private...ing developer of oncology compounds directed to ca...ty of Texas M.D. Anderson Cancer Center (Houston, ...aboration. As part of this collaboration, M.D. And...ial of SL-401 in patients with acute myeloid leuke...
(Date:11/30/2009)... Nov. 30 Amgen Inc. (Nas...updated long-term safety and efficacy data for Npl...diopathic) thrombocytopenic purpura (ITP). Additio...n a pediatric setting as well as in patients with ...an Society of Hematology (ASH) Annual Meeting and ...
Breaking Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center 2Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 1SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 2SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 3SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 4SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 5SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 6SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 7SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 8More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 1More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 2More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 3More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 4More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7
...mpany Misrepresented Prescription Pain,Reliever to...May 10, 2007-The U.S. Food and Drug,Administration...nnounced today that The Purdue Frederick Company, ...esolve criminal charges and civil,liabilities in c...,market and sell OxyContin, a powerful prescriptio...
...DA Equipped to Meet Pace of Innovations and a Heal...PRNewswire-USNewswire/ -- The Food,and Drug Admini...changes in the history of healthcare, Commissioner...and Drug Law Institute,s 50th,Annual Conference Ap...bridging" ways to use its limited,financial and pe...
Other Medicine Technology:FDA Announces Results of Investigation Into Illegal Promotion of,OxyContin by The Purdue Frederick Company, Inc. 2FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,FDA Regulations 2
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products: